Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?

Infection

Volumn 34, Issue 5, 2006, Pages 282-284

  Orlando, R ^a   Tosone, G ^a   Tiseo, D ^a   Piazza, M ^a   Portella, G ^a   Ciancia, R ^a   Martinelli, V ^a   Montante, B ^a   Rotoli, B ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMIVUDINE; RECOMBINANT ALPHA INTERFERON; VIRUS DNA; VIRUS RNA;

ACUTE HEPATITIS; AGED; ARTICLE; CANCER PATIENT; CASE REPORT; DISEASE SEVERITY; HAIRY CELL LEUKEMIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; MALE; SEROCONVERSION; SPLENECTOMY; VIRUS REACTIVATION;

AGED; ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LEUKEMIA, HAIRY CELL; MALE; VIRUS ACTIVATION;

EID: 33749838706     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-4150-8     Document Type: Article

References (10)

1. Dhedin N, Douvin C, Kuentz M, Saint Marc MF, Reman O, Rieux C, Bernaudin F, Norol F, Cordonnier C, Bodin D, Metreau JM, Vernant JP: Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998; 66: 616-619.
2. NordbØ SA, Skaug K, Holter E, Waage A, Brinch L: Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol 2000; 65: 86-87.
3. Simpson ND, Simpson PW, Ahmed AM, Nguyen MH, Garcia G, Keeffe EB, Ahmed A: Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine. J Clin Gastroenterol 2003; 37: 68-71.
4. Martin BA, Rowe JM, Kouides PA, DiPersio JF: Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 1995; 15: 145-148.
5. Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh SR, Liu RS, Tzeng CH: Reactivation of hepatitis B virus in two chronic GVHD patients after transplant. Int J Hematol 1993; 58: 183-188.
6. Picardi M, Selleri C, De Rosa G, Raiola A, Pezzullo L, Rotoli B: Lamivudine treatment of chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 1267-1269.
7. Romand F, Michallet M, Pichoud C, Trepo C, Zoulim F: Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B. Gastroenterol Clin Biol 1999; 23: 770-774.
8. Da Villa G: Rationale for the infant and adolescent vaccination programmes in Italy. Vaccine 2000; 18: S31-S34.
9. European Association for the Study of Liver: EASL international consensus conference on Hepatitis B. J Hepatol 2003; 38: 533-540.
10. Keeffe EB: Hepatitis B virus reactivation with chemotherapy: diagnosis and prevention with antiviral prophylaxis. Rev Gastroenterol Disord 2004; 4: 46-48.